| TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
|---|---|---|---|---|---|
| 2022 | USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1 | Cells | 7.607 | 36291159 | |
| 2022 | The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs | Biomedicine & Pharmacotherapy | 7.419 | 36068781 | |
| 2022 | The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2 | Biomedicine & Pharmacotherapy | 7.419 | 36081287 | |
| 2022 | Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy | Biomedicine & Pharmacotherapy | 7.419 | 36007272 | |
| 2018 | Aryl Hydrocarbon Receptor activation by diesel exhaust particles mediates epithelium-derived cytokines expression in severe allergic asthma | Allergy. | 7.361 | 29672862 | |
| 2018 | Plant galactolipid dLGG suppresses lung metastasis of melanoma through deregulating TNF-α−mediated pulmonary vascular permeability and circulating oxylipin dynamics in mice | Int J Cancer. | 7.36 | 29978476 | |
| 2018 | miR‐134 targets PDCD7 to reduce E‐cadherin expression and enhance oral cancer progression | Int J Cancer. | 7.36 | 29971778 | |
| 2022 | CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance | Clinical Epigenetics | 7.259 | 35999564 | |
| 2022 | CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance | Clinical Epigenetics | 7.259 | 35999564 |
